We built a LASSO model with PRAME, CDKN2A, and STC2 and checked it using Kaplan-Meier analysis and ROC curves over time, while STC2 was further identified as the key mediator linking PFC exposure to CRC risk based on Mendelian randomization and experimental validation. This evidence concerns the gene PRAME and colorectal carcinoma.